CN Patent

CN100339085C — 治疗心脑血管疾病的中药组合物

Assigned to Tasly Pharmaceutical Group Co Ltd · Expires 2007-09-26 · 19y expired

What this patent protects

本发明公开一种治疗心脑血管疾病的中药组合物，它由丹参提取物5.0%～70.0%、三七提取物10.0%～85.0%、黄芪提取物5.0%～70.0%、冰片或降香油1.0%～15.0%组成，具有明显的抗脑缺血、心肌缺血作用，其疗效优于单独使用丹参总酚酸或三七总皂苷，也优于丹参总酚酸加三七总皂苷，为临床提供了一种疗效更好、更加方便的中药有效部位复方组合物及其制剂。

USPTO Abstract

本发明公开一种治疗心脑血管疾病的中药组合物，它由丹参提取物5.0%～70.0%、三七提取物10.0%～85.0%、黄芪提取物5.0%～70.0%、冰片或降香油1.0%～15.0%组成，具有明显的抗脑缺血、心肌缺血作用，其疗效优于单独使用丹参总酚酸或三七总皂苷，也优于丹参总酚酸加三七总皂苷，为临床提供了一种疗效更好、更加方便的中药有效部位复方组合物及其制剂。

Drugs covered by this patent

Patent Metadata

Patent number
CN100339085C
Jurisdiction
CN
Classification
—
Expires
2007-09-26
Drug substance claim
No
Drug product claim
No
Assignee
Tasly Pharmaceutical Group Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.